We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$184B
| $306M | 0.78% |
2,242,499
-30,460
| -1% | -$4.15M |
|
27
Mastercard
MA
$469B
| $296M | 0.76% |
989,990
-3,101
| -0.3% | -$874K |
|
28
Walmart Inc
WMT
$863B
| $290M | 0.74% |
7,315,878
-28,626
| -0.4% | -$1.14M |
|
29
Eli Lilly
LLY
$1.06T
| $284M | 0.73% |
2,162,179
-2,860
| -0.1% | -$332K |
|
30
Pfizer
PFE
$143B
| $283M | 0.72% |
7,616,805
-136,957
| -2% | -$4.88M |
|
31
iShares MSCI EAFE Value ETF
EFV
$27.3B
| $280M | 0.72% |
5,605,438
+316,054
| +6% | +$15.5M |
|
32
Accenture
ACN
$84.9B
| $265M | 0.68% |
1,260,518
-20,652
| -2% | -$4.03M |
|
33
Chevron
CVX
$387B
| $259M | 0.66% |
2,147,893
-71,340
| -3% | -$8.4M |
|
34
iShares MSCI USA Min Vol Factor ETF
USMV
$23B
| $259M | 0.66% |
3,944,856
-77,870
| -2% | -$5M |
|
35
AbbVie
ABBV
$454B
| $255M | 0.65% |
2,878,054
-204,445
| -7% | -$17M |
|
36
Abbott
ABT
$175B
| $254M | 0.65% |
2,924,694
-75,175
| -3% | -$6.3M |
|
37
Home Depot
HD
$324B
| $246M | 0.63% |
1,125,837
-21,425
| -2% | -$4.85M |
|
38
Invesco QQQ Trust
QQQ
$460B
| $241M | 0.61% |
1,131,178
-8,100
| -0.7% | -$1.62M |
|
39
iShares Russell 1000 Growth ETF
IWF
$123B
| $232M | 0.59% |
5,278,304
-25,904
| -0.5% | -$1.08M |
|
40
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $231M | 0.59% |
5,141,495
-62,021
| -1% | -$2.66M |
|
41
McDonald's
MCD
$187B
| $230M | 0.59% |
1,164,535
-12,915
| -1% | -$2.56M |
|
42
iShares Russell 1000 ETF
IWB
$47.7B
| $230M | 0.59% |
1,288,936
+39,874
| +3% | +$6.8M |
|
43
American Tower
AMT
$76.7B
| $222M | 0.57% |
965,801
+8,524
| +0.9% | +$1.86M |
|
44
Bank of America
BAC
$430B
| $219M | 0.56% |
6,226,623
-40,473
| -0.6% | -$1.31M |
|
45
PACCAR
PCAR
$68.8B
| $211M | 0.54% |
3,995,729
-6,792
| -0.2% | -$349K |
|
46
Emerson Electric
EMR
$81.2B
| $205M | 0.52% |
2,686,670
-51,049
| -2% | -$3.68M |
|
47
Visa
V
$669B
| $204M | 0.52% |
1,087,705
-24,139
| -2% | -$4.35M |
|
48
Walt Disney
DIS
$161B
| $198M | 0.51% |
1,368,347
+8,987
| +0.7% | +$1.25M |
|
49
Wells Fargo
WFC
$261B
| $197M | 0.5% |
3,662,016
-101,473
| -3% | -$5.31M |
|
50
Target
TGT
$61.1B
| $196M | 0.5% |
1,524,941
-24,771
| -2% | -$2.91M |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.